Introduction {#s1}
============

DMD is the most common X-linked fatal neuromuscular disorder. The disease affects males from early childhood and death usually occurs in the second to third decade of life due to ventilatory and cardiac failure [@pone.0069567-Engel1], [@pone.0069567-Hoffman1], [@pone.0069567-Baydur1], [@pone.0069567-Beck1], [@pone.0069567-Phillips1], [@pone.0069567-Mosqueira1]. The disease is caused by mutations in the DMD gene resulting in an absence of dystrophin in muscle and neurons. While muscular weakness and wasting are the most well recognized signs and symptoms of DMD, some but not all patients also present with neurological manifestations exemplified by mental retardation and abnormalities in retinal function [@pone.0069567-Anderson1], [@pone.0069567-Pillers1]. Dystrophin is a 427 KDa protein, located sub- sarcolemmally and forms a critical part of the dystrophin- glycoprotein complex. In muscle, the absence of dystrophin renders the sarcolemma susceptible to damage and degeneration by mechanical forces during repeated cycles of muscle contraction and relaxation [@pone.0069567-Brown1], [@pone.0069567-Moens1], [@pone.0069567-Petrof1]. The progressive muscle damage resulting in necrosis and fibrosis has been extensively studied in DMD patients. Histological analysis of limb muscles from DMD patients reveal overexpression of TGF-β1, connective tissue growth factor, proliferation of heparin-sulphate proteoglycans, collagen type III, adipose tissue and infiltration of immune cells [@pone.0069567-Alvarez1], [@pone.0069567-Arahata1], [@pone.0069567-Bernasconi1], [@pone.0069567-Duance1], [@pone.0069567-Gorospe1], [@pone.0069567-McDouall1]. The consequence of the structural tissue damage in DMD patients is an impairment of respiratory function, which has been described as a restrictive ventilatory syndrome [@pone.0069567-Hukins1], [@pone.0069567-Inkley1], [@pone.0069567-McDonald1], [@pone.0069567-Rideau1], [@pone.0069567-Tangsrud1]. DMD patients show a positive correlation between the rates of decrease in vital capacity (VC) and forced expiratory volume in 1 second (FEV~1~) and a decrease in maximal inspiratory pressure as the disease progresses [@pone.0069567-Gayraud1]. Other factors, such as an alteration of the elastic properties of elastin and collagen fibers, a decrease in surfactant activity and fibrosis reduces the ventilatory system compliance [@pone.0069567-DeTroyer1], [@pone.0069567-Estenne1], [@pone.0069567-Lynn1], [@pone.0069567-Smith1]. The decrease of functional residual capacity and maximal inspiratory effort is correlated with an increase of the diaphragm thickness in DMD patients due to increased connective tissue [@pone.0069567-DeBruin1]. Muscle damage in the diaphragm and other respiratory muscles leads to a reduced trans-diaphragmatic pressure, peak inspiratory flow during forced VC and tidal volume, which in turn leads to a chronic condition of hypercapnia and hypoxemia and eventually respiratory failure [@pone.0069567-Baydur1], [@pone.0069567-Beck1], [@pone.0069567-Phillips1], [@pone.0069567-DeBruin2], [@pone.0069567-Gell1], [@pone.0069567-Park1].

The carotid body (CB) is the primary peripheral chemoreceptor that responds to hypoxemia, hypercapnia and acidosis stimuli. These stimuli increase the minute ventilation in order to reestablish the arterial oxygen and/ or carbon dioxide pressure and/ or pH via CB efferents [@pone.0069567-Eyzaguirre1], [@pone.0069567-Gonzalez1]. In the CB, the cellular response to hypoxia is mediated by the hypoxia inducible factor (HIF) [@pone.0069567-Bunn1], [@pone.0069567-Metzen1], [@pone.0069567-Zagrska1] pathway as well s transcription factors including AP-1, NFκB and TP53 [@pone.0069567-Dachs1]. Both, systemic and cellular responses to hypoxia are considered to be defensive responses; however, the chronic exposure to hypoxia can result in various pathological situations, including *cor pulmonale* [@pone.0069567-Essop1].

The murine animal model (*mdx*) of DMD has extensively been used to understand the pathophysiology of the disease. In particular, the *mdx* mouse diaphragm faithfully reproduces many patho-physiological and histological features seen in human DMD patients [@pone.0069567-Engel1], [@pone.0069567-Stedman1], [@pone.0069567-Dellorusso1], [@pone.0069567-Pastoret1], [@pone.0069567-Pastoret2]. It has been described that the dystrophic diaphragm shows a significant contractile fatigue and has a reduced ability to precisely and consistently generate force following both nerve and muscle stimulation at 35 Hz [@pone.0069567-Personius1]. Several ventilatory studies have been performed in *mdx* mice [@pone.0069567-DupontVersteegden1], [@pone.0069567-DupontVersteegden2], [@pone.0069567-Farkas1], [@pone.0069567-Gayraud2], [@pone.0069567-Huang1], [@pone.0069567-Ishizaki1], [@pone.0069567-Matecki1] that in common document the respiratory involvement, however, yielding some inconsistencies in terms of specific features of their responses to hypercapnic [@pone.0069567-Gayraud2], [@pone.0069567-Matecki1], normoxic and hypoxic stimuli [@pone.0069567-Farkas1], [@pone.0069567-Huang1], [@pone.0069567-Ishizaki1]. Despite being well studied, lacunae exist regarding the peripheral chemosensory drive in dystrophin-deficiency and there is a lack of consensus about the integrity of basic ventilatory reflexes in *mdx* mice. To address these issues we studied ventilatory parameters using a non-invasive whole body plethysmograph (WBP), as well as performed examination of the phrenic nerve activity and the arterial blood gases from adult *mdx* mice. To determine the potential role of dystrophin in the peripheral chemosensory reflexes, we studied the expression of dystrophin mRNA and protein in the CB peripheral arterial chemoreceptor, as well as performed functional assessment of CB chemosensory drive in normal and *mdx* mice.

Materials and Methods {#s2}
=====================

Animals {#s2a}
-------

Adult male normal (C57BL/10ScSn) and *mdx* (C57BL/10ScSn-Dmd*^mdx^*/J) mice obtained from the Jackson Laboratory (Jackson Laboratory, Bar Harbor, ME) were kept in the animal facility at the University of Pennsylvania School of Medicine until 6--7 month of age. All animal experiments were performed according to U.S. laws and were approved by the Institutional Animal Care and Use Committee at the University of Pennsylvania, School of Medicine, and all effort were made to minimize suffering.

Measurement of Respiratory parameters via WBP {#s2b}
---------------------------------------------

To measure respiratory parameters as well as HVR and HCVR, we custom-built a non-invasive WBP chamber (radius 2.5 cm; height 10.0 cm) with gas administration ports and a polyethylene base, with a final volume of 150 mL ([Figure S1A](#pone.0069567.s001){ref-type="supplementary-material"}). A MLT1L pneumotachometer (AD Instruments Inc., Colorado Springs, CO) was connected to the outlet port and the difference of pressure integrated using a ML140 Spirometer module (AD Instruments). The analog signal was converted to digital using Power Lab 8/SP (AD Instruments), filtered at 10 Hz and acquired at 400 B/s with the Chart 4.2.4 data acquisition system (AD Instruments) and stored in a PC. Calibration was performed according to the manufacturer\'s manual.

HVR and HCVR protocols {#s2c}
----------------------

Unanesthetized freely-moving normal and *mdx* mice age 6 to 7 months were allowed to acclimatize to the WBP chamber for 30--60 min/ day for 4 days while flushing with fraction of inspired oxygen (FiO~2~) 21% at 0.5 L/ min before the actual experiments. Required gas mixtures were obtained using a commercial gas mixer (Pegas-400 MF Gas Mixer, Columbus Instruments, Columbus, OH, USA) set at 1 L/ min combined with a manual flow meter to regulate the flow into the chamber at a final flow rate of 0.5 L/ min. To determine the HVR, acclimatized normal and *mdx* mice (n = 5 each), were subsequently exposed to FiO~2~ of 100, 21, 18, 15, 12, 10 and 8% O~2~- balanced in N~2~ each interspaced by 10 minutes of normoxia until a steady response was obtained. To determine the HCVR, the animals were subsequently exposed to fractions of inspired CO~2~ (FiCO~2~) e.g. 5% CO~2~-balanced with air, 5% CO~2~-balanced with 95% O~2~, 10% CO~2~-balanced with air and 10% CO~2~-balanced with 90% O~2~ until a steady response was recorded. The different hypercapnic challenges were interspaced by 10 minutes of normoxia. Normalized minute ventilation (, µL/ s/ g) measured from normal and *mdx* mice was calculated from the respiratory rate (*f* ~R~, Hz) multiplied by tidal volume normalized to body weight (V~T~, µL/ g). The analysis was performed from three different measurements with at least 20 s of steady breathing without behavioral and/ or physical activity of the animals. To avoid interference of thoracic movements at V~T~ values during inspiration and expiration, a correction factor was multiplied to normalized V~T~. This correction factor was obtained from the ratio between the normalized V~T~ of the nose plethysmograph and the normalized V~T~ of the WBP from five different normal mice. The detailed protocol description is available at TREAT-NMD website: SOP- Respiratory System Evaluation, DMD_M.2.2.002: <http://www.treat-nmd.eu/downloads/file/sops/dmd/MDX/DMD_M.2.2.002.pdf>

Hypoxic stress test {#s2d}
-------------------

To determine the resistance to severe hypoxia, anesthetized age matched normal and *mdx* mice (n = 14) were exposed to FiO~2~ 8% (hypoxia) in the WBP chamber, as described above. Hyperventilation and ventilatory disturbances during FiO~2~ 8% were monitored carefully to avoid fatality. The time (in seconds) between the beginning of tachypnea and the first apneic pause after being exposed to FiO~2~ 8% was measured.

Phrenic nerve activity {#s2e}
----------------------

Age matched normal and *mdx* mice were anesthetized with ketamine (80 mg/Kg) and xylazine (20 mg/Kg), followed by an additional dose of ketamine when required to maintain surgical level of anesthesia. Phrenic nerve activity was monitored as an index of central respiratory neuronal output. The phrenic nerve was isolated unilaterally at the level of the C5 and C6 spinal segments, placed on a bipolar platinum electrode and lifted on mineral oil. The neural discharge was pre-amplified using an AC Preamplifier Model P-15 (Grass Instruments, Quincy, Massachusetts, USA), filtered (100 Hz -- 3 KHz), the analog signal was converted to digital using a PowerLab (AD Instruments), acquired at 1 KB/s using Chart 4.2.4 (AD Instruments). To determine the hypoxic response on the phrenic nerve activity, animals (n = 4 each) were exposed three times to each FiO~2~ 100, 21, 8, 4 and 0% O~2~-balanced in N~2~, until a steady response was recorded. Care was taken to avoid death by anoxia. The frequency of phrenic nerve discharge and each burst of the phrenic nerve activity were analyzed from three different responses of the same FiO~2~ challenge.

Arterial blood gas analysis and hematocrit {#s2f}
------------------------------------------

The carotid artery was cannulated with heparin-coated PE-50 tubing in anesthetized animals for arterial blood sampling. Two arterial blood samples were collected and immediately injected into an ABL700 Radiometer (Radiometer America, USA) to measure oxygen and carbon dioxide partial gas pressure (PO~2~ and PCO~2~) and pH. The hydrogen carbonate (HCO) was calculated by an ABL700 Radiometer from PaCO~2~ values. The hematocrit was calculated from the percentage of red blood cells in the total blood sample after centrifugation (Micro-capillary centrifuges model MB, International equipment Co. Boston, MA).

RNA isolation and qPCR {#s2g}
----------------------

Total RNA was extracted with TRIzol reagent (Invitrogen) from *tibialis anterior* muscle and pooled CBs from age-matched normal and *mdx* mice and purified using the RNeasy kit (Qiagen, Valencia, CA) following the manufacturer\'s instructions. Five µg of total RNA was reverse transcribed using random hexamers (Invitrogen) and the SuperScript™FirstStrand enzyme (Invitrogen). The mouse dystrophin TaqMan assay Mm00464475_m1 from Applied Biosystems (Applied Biosystems, Foster City, CA) was used to determine dystrophin mRNA expression. cDNA corresponding to 25 ng of total RNA was amplified in 20 µl of reaction mixture-containing 1 µl of primer mix and 10 µl of 2× TaqMan universal PCR master mix (Applied Biosystems). The amplification was performed in a 7900HT Sequence Detection System (Applied Biosystem).

Immunoblotting {#s2h}
--------------

Total protein was extracted from the CBs of normal and *mdx* mice with TNEC (50 mM Tris-HCl, pH 8.0; 150 mM NaCl; 1% NP40; 2 mM EDTA) buffer containing complete protease inhibitor cocktail (Roche, Basel, Switzerland). Protein concentration was determined using the Bradford Assay (Bio-Rad, Hercules, CA). For dystrophin immunoblotting, 50--75 µg of total protein was resolved on 3--8% Tris-Acetate gradient gels (NuPage; Invitrogen) and electro-transferred onto poly-vinylidene difluoride (PVDF) membranes (Immobilon P, Millipore, Billerica, MA). After blocking with 5% nonfat-milk in wash buffer (0.05 M Tris, 0.15 M NaCl, 0.05% Igepal CA630 and 0.1% BSA), blots were incubated overnight with dystrophin antibody (1∶500, Vector Laboratories, Burlingame CA) at 4°C. Blots were washed and incubated with either goat anti-rabbit or anti-mouse HRP-conjugated secondary antibodies at 1∶20,000 (Jackson ImmunoResearch) dilutions to detect protein bands using an enhanced chemiluminescence kit (Pierce). Membranes were re-probed with anti-mouse α-tubulin (1∶6000; Sigma) to confirm equal loading (data not shown).

Dejours test and analysis of the HCVR fast component {#s2i}
----------------------------------------------------

Age-matched normal and *mdx* mice were anesthetized with a ketamine- xylazine mix as described. Using a custom made mouse mask (adapted to the mouse\'s snout; [Figure S1B](#pone.0069567.s001){ref-type="supplementary-material"}) attached to a pneumotachometer, signal acquisition and A/D conversion was performed as mentioned above. Four animals per group were breathing FiO~2~ 21% for 3 min and quickly switched to FiO~2~ 100% for 60 s.

A similar procedure was performed to test the HCVR fast component. A different set of 4 anesthetized animals per group were breathing FiO~2~ 21% for 3 minutes and then were quickly switched to either air-balanced hypercapnia (FiCO~2~ 5%- FiO~2~ 21%) or O~2~-balanced hypercapnia (FiCO~2~ 5%- FiO~2~ 95%) for 60 s. The analysis of *f* ~R~ and V~T~ was performed in the first 10 s of either air-balanced hypercapnia or O~2~-balanced hypercapnia exposure. The percentage of ventilatory change from preceding normoxia exposure to either hyperoxia (Dejours test), air-balanced hypercapnia or O~2~-balanced hypercapnia was calculated.

Statistical Analysis {#s2j}
--------------------

All data were analyzed using GraphPad Prism 5.0 software (GraphPad Inc., La Jolla, CA). Respiratory and phrenic nerve activity differences were analyzed by a non-parametric ANOVA and Dunn post-test. The frequency of ventilation and discharge of the phrenic nerve was analyzed using a sigmoidal dose-response curve for variable slope. The arterial blood gases, Dejours test and the fast component of hypercapnia responsiveness data were analyzed using a non-parametric t-test. Values were considered statistically significant if p\<0.05. The tests as described above were repeated three times for each animal. All results are shown as the mean ± SEM.

Results {#s3}
=======

Blunted HVR to mild hypoxia in *mdx* mice {#s3a}
-----------------------------------------

To study hypoxia ventilatory response (HVR) and hypercapnia ventilatory response (HCVR), normal and *mdx* mice were acclimated to a custom-built WBP chamber using room air (equivalent of a FiO~2~ of 21%). Mice were then challenged with different FiO~2~ and FiCO~2~ levels and *f* ~R~, V~T~ and values obtained HVR was tested in normal and *mdx* mice using different FiO~2~ values ([Figure 1A](#pone-0069567-g001){ref-type="fig"}). *Mdx* mice showed a significantly lower *f* ~R~ reduced V~T~ and when exposed to room air ([Fig. 1A, 1B, 1C](#pone-0069567-g001){ref-type="fig"} and [Table S1](#pone.0069567.s004){ref-type="supplementary-material"}). A significant reduction in the *f* ~R~ was observed during mild hypoxic challenges (FiO~2~ 18 and 15%), but not during moderate (FiO~2~ 10 and 12%) and severe hypoxic challenges (FiO~2~ 8%; [Figure 1B](#pone-0069567-g001){ref-type="fig"}). Although there were no significant changes in normalized V~T~ during hypoxic challenges in *mdx* relative to normal mice, *mdx* mice showed significantly lower normalized V~T~ values at FiO~2~ 21% and higher V~T~ values at FiO~2~ 100% ([Figure 1C](#pone-0069567-g001){ref-type="fig"}). was significantly different at the same FiO~2~ levels as noted for *f* ~R~ ([Figure 1D](#pone-0069567-g001){ref-type="fig"}).

![HVR of normal and *mdx* mice exposed to different FiO~2~ levels.\
A) Representative inspiratory and expiratory flows obtained from normal (top) and *mdx* mice (bottom) exposed to FiO~2~ 21, 18, 15, 12, 10, 8 and 100%. Each animal was challenged three times with each FiO~2~. The scale for tidal volume (V~T~, µL) and time (s) are shown at bottom right. B) Quantification of respiratory frequency (*f* ~R~, Hz), C) tidal volume normalized by body weight (µL/g) and D) minute ventilation () normalized by body weight (µL/s/g) from normal (empty bars) and *mdx* (filled bars) mice at each FiO~2~ levels tested. Mean ± SEM; \* p\<0.05; \*\* p\<0.01, n = 5.](pone.0069567.g001){#pone-0069567-g001}

To determine whether the blunted response to hypoxia was due to a lower phrenic nerve activity (*f* ~x~) input to the main respiratory muscle, we extended the hypoxic challenge in anesthetized animals to FiO~2~ 0, 4 and 8% in addition to FiO~2~ 21 and 100% and recorded *f* ~x~. Analysis showed a significant reduction of *f* ~x~ in *mdx* mice during normoxia (FiO~2~ 21%) and at FiO~2~ 100% compared to normal mice ([Figure 2A](#pone-0069567-g002){ref-type="fig"}), similar to the *f* ~R~ response pattern described above using WBP. These results suggest a blunted ventilatory response in *mdx* mice compared to normal mice ([Table S2](#pone.0069567.s005){ref-type="supplementary-material"}). As previously described in other mice strains [@pone.0069567-Erhardt1], [@pone.0069567-Sarton1], the difference between the normoxic *f* ~x~ and normoxic *f* ~R~ results observed here in both normal and *mdx* mice was due to the effect of anesthesia. We also analyzed in both groups the phrenic nerve burst frequency, which showed no significant change at different levels of FiO~2~ ([Figure 2C](#pone-0069567-g002){ref-type="fig"}), suggesting that the phrenic nerve activity and the central generator of ventilation in the medulla were intact.

![Phrenic nerve activity of anesthetized normal and *mdx* mice in response to hypoxia and hyperoxia challenges.\
A) Analysis of phrenic nerve activity frequency of discharge (*f* ~x~, Hz) from normal (square, continuous line) and *mdx* mice (filled circle, broken line) in response to FiO~2~ 0, 4, 8, 21 and 100%. Each animal was challenged three times with each FiO~2~. B) Analysis of the average of each phrenic nerve burst during the response to FiO~2~ 0, 4, 8 and 100%. The data was normalized by the normoxic response activity (FiO~2~ 21%). Mean ± SEM; \* p\<0.05, n = 5.](pone.0069567.g002){#pone-0069567-g002}

The volitional requirements of clinically useful tests of pulmonary functions (e.g. FVC and FEV~1~) precluded measurements in mice; hence we designed a hypoxic stress test to estimate ventilatory capacity and integrity of respiratory drive in mice. We observed that a quick change from FiO~2~ 21% to FiO~2~ 8% induced apneic pauses in both normal and *mdx* mice after a few seconds of hyperventilation ([Figure 3A](#pone-0069567-g003){ref-type="fig"}). Compared to normal mice the lapsed time between the beginning of hyperventilation induced by severe hypoxic challenge and the first apneic pause was significantly reduced in *mdx* mice (22.40±9.67 *vs.* 16.67±4.90 s; [Figure 3B](#pone-0069567-g003){ref-type="fig"}). This result suggests impairment in the ventilatory response mediated either by reduced muscle function in response to acute intense hypoxia induced activity in *mdx* mice exposed to severe hypoxic conditions and/or a reduced or altered respiratory drive.

![Time between the beginning of tachypnea and the first apneic pause during severe hypoxic challenge.\
A) Normal and *mdx* mice were exposed from normoxia to severe hypoxia (FiO~2~ 8%) and the time (seconds) between the hypoxia-induced tachypnea response (arrows) and apneic pause (arrow heads) was calculated. Each animal was challenged twice. B) Quantification of the time to first apneic pause. Mean ± SEM; \* p\<0.05, n = 14.](pone.0069567.g003){#pone-0069567-g003}

Normal HCVR in *mdx* mice {#s3b}
-------------------------

In order to separate the CB chemosensory hypercapnic response from the central (brainstem) hypercapnic response [@pone.0069567-Putnam1], we used two different types of hypercapnic mixes: CO~2~ balanced in air \[to induce both the peripheral (CB) and central chemosensory response\] and CO~2~ balanced in O~2~ (to induce the central chemosensory response only and make the CB chemosensory response feeble or absent). The analysis was performed after ca. 60 s of the hypercapnic stimulus, once the ventilation showed a stable response without interference by the animal\'s behavior. Compared to the normoxic response, *mdx* mice presented a significantly higher *f* ~R~ and normalized V~T~ response at any hypercapnic level ([Table S3](#pone.0069567.s006){ref-type="supplementary-material"}). However, compared to normal mice, *mdx* mice did not show any significant change in the magnitude of change in response to hypercapnia in *f* ~R~, V~T~ and hence in ([Figure S2](#pone.0069567.s002){ref-type="supplementary-material"}). These results suggested that HCVR in *mdx* mice at 6--7 months of age did not differ from normal mice.

Altered arterial blood gases and hematocrit levels in *mdx* {#s3c}
-----------------------------------------------------------

Having established that *mdx* mice had lower *f* ~R~ and V~T~ in normoxia and a blunted HVR to mild hypoxia, we asked if these changes in respiratory parameters would lead to alterations in arterial blood gasses during normoxic ventilation. Indeed, compared to normal mice, the *mdx* mice presented reduction of PaO~2~ (113.2±18.0 *vs.* 61.56±7.04 mmHg; [Figure 4A](#pone-0069567-g004){ref-type="fig"}), increased PaCO~2~ (39.98±9.56 *vs.* 89.02±15.70 mmHg, [Figure 4B](#pone-0069567-g004){ref-type="fig"}). Along with the reduced PaO~2~ and increased PaCO~2~ the arterial blood of the *mdx* mice had decreased pH (7.42±0.04 *vs.* 7.00±0.14; [Figure 4C](#pone-0069567-g004){ref-type="fig"}) compared to normal mice. There was a tendency towards lower levels of HCO in *mdx* arterial blood (24.76±4.13 *vs.* 21.18±4.56 mmHg); however, this was not significant. The hematocrit of arterial blood ([Figure 4D](#pone-0069567-g004){ref-type="fig"}) was significant higher in *mdx* mice relative to normal mice (40.75±0.50 *vs.* 44.75±1.32).

![Arterial blood gases and hematocrit values obtained from normal and *mdx* mice during normoxic ventilation.\
Three arterial blood samples from each of five anesthetized normal (empty bars) and *mdx* (filled bars) mice were taken to measure A) PaO~2~, B) PaCO~2~, C) pH, and D) hematocrit. Mean ± SEM; \* p\<0.05.](pone.0069567.g004){#pone-0069567-g004}

Absence of dystrophin in the *mdx* carotid body {#s3d}
-----------------------------------------------

To understand the origin of the blunted HVR observed in *mdx* mice, we investigated the CB, the major chemosensory organ responsible to sense changes in PaO~2~ as well as changes in PaCO~2~ and pH. First, we used qPCR to determine that dystrophin mRNA is expressed in CB of normal mice albeit at levels less than in TA muscle, however, it is absent in *mdx* mice ([Figure 5A](#pone-0069567-g005){ref-type="fig"}). The delta Ct values obtained from normal TA and CB were 18. 85±0.31 and 25.51±0.07, respectively (mean ± SD). As expected, dystrophic TA and CB yielded undetermined delta CT values, indicating that dystrophin is expressed in normal CB but not in dystrophic CB. Second, we used Western blotting to determine that full length dystrophin protein is expressed in the CB of normal mice, however, it was absent in *mdx* mice ([Figure 5B](#pone-0069567-g005){ref-type="fig"}). These results demonstrate that dystrophin mRNA and protein is expressed in normal CB and supports the idea that its absence in dystrophic CB may be, in part, responsible for the alterations in chemosensory drive observed in *mdx* mice.

![Expression of dystrophin in the CB from normal and *mdx* mice.\
A) Dystrophin mRNA expression level in the CB from normal mice is similar to that in *tibialis anterior*, whereas dystrophin mRNA was not detected in the two tissues from *mdx* mice. The delta Ct values obtained were TA 18. 85±0.31 and CB 25.51±0.07 (mean ± SD). Dystrophic TA and CB amplification were under the minimum level of detection, being considered as undetermined. B) Immunoblot showing expression of full length dystrophin protein in CB from normal mice and absence in CB from *mdx* mice.](pone.0069567.g005){#pone-0069567-g005}

Blunted chemosensory drive in *mdx* mice {#s3e}
----------------------------------------

The results presented above allowed us to hypothesize that CB is responsible for the blunted ventilatory response in *mdx* mice. To test the hypothesis that dystrophin may play a role in the CB chemosensory drive, we performed two tests that can report the functioning of the CB chemosensory drive: the Dejours test [@pone.0069567-Dejours1] adapted to small animals [@pone.0069567-Fernndez1], [@pone.0069567-Kline1] and tests for the fast (peripheral) and slow (central) component of the HCVR to dissect the response induced by CB and the central chemosensory neurons [@pone.0069567-Dahan1], [@pone.0069567-Rodman1]. In normal anesthetized mice, exposure to hyperoxia (FiO~2~ 100%) induced a reduction of the *f* ~R~ during the first 10 s of exposure demonstrating normal CB functioning; however, a positive Dejours test or significant attenuation of the hyperoxia-induced reduction *f* ~R~ was observed in anesthetized *mdx* mice ([Figure 6A](#pone-0069567-g006){ref-type="fig"}; [Table S4](#pone.0069567.s007){ref-type="supplementary-material"}). As expected for the Dejours test, the V~T~ (percentage of basal) of the HVR was increased compared to normoxia in both genotypes ([Figure 6B](#pone-0069567-g006){ref-type="fig"}). The V~T~ from *mdx* was higher than in normal, although this difference was not statistically significant ([Figure S3](#pone.0069567.s003){ref-type="supplementary-material"}).

![Reduced peripheral chemosensory drive in anesthetized *mdx* mice.\
A) The Dejours test adapted to small rodents was utilized and the first 10 s of hyperoxia exposure were analyzed. The peripheral chemosensory drive was significantly affected in *mdx* mice compared to normal mice. B) The first 10 s of exposure to air-balanced hypercapnia or O~2~-balanced hypercapnia were analyzed as the fast component of the HCVR. The HCVR induced by air-balanced hypercapnic gas mix (empty bar) was attenuated in normal mice compared to the HCVR induced by the hyperoxia-balanced hypercapnia mix (hatched bar). In the *mdx* mice, the early HCVR induced by air-balanced hypercapnic gas mix (gray bar) was similar to the early HCVR induced by the hyperoxia-balanced hypercapnia gas mix (filled bar). The analysis also showed a significant attenuation of the fast component of the HCVR in *mdx* mice compared to normal mice exposed to either air-balanced or hyperoxia-balanced hypercapnic gas mixtures. Mean ± SEM; \* p\<0.05, \*\*\* p\<0.001. n = 4.](pone.0069567.g006){#pone-0069567-g006}

To accurately dissect the peripheral (fast response) and central (slow response) from the total HCVR, we exposed anesthetized animals to one minute of an air-balanced hypercapnic gas mixture obtaining a full peripheral chemosensory response. Animals were first allowed to recover (normoxia for 10 minutes) and then challenged using a hyperoxia-balanced hypercapnic gas to inhibit the tonic peripheral chemosensory response. The *f* ~R~ of *mdx* mice was significantly reduced compared to the *f* ~R~ in normal mice after a 10 s exposure to air-balanced hypercapnic or hyperoxia-balanced hypercapnic gas mixtures. This result demonstrates attenuation in the fast component of the HCVR in *mdx* mice ([Figure 6B](#pone-0069567-g006){ref-type="fig"}; [Table S5](#pone.0069567.s008){ref-type="supplementary-material"}). As expected, the normal mice reduced the *f* ~R~ when exposed to a hyperoxia-balanced hypercapnic gas compared to an air-balanced hypercapnic gas, showing that hyperoxia is able to chemically inhibit the tonic activity of the CB. In contrast, we did not observe any difference in *f* ~R~ of *mdx* mice for either air-balanced hypercapnic or hyperoxia-balanced hypercapnic gas mixtures. These results also suggest that the peripheral CB chemosensory drive rather than central chemosensory drive is attenuated in the 6--7 month-old *mdx* mice.

Discussion {#s4}
==========

The present study supports the hypothesis that the absence of dystrophin impairs normal ventilation and extends it to the ventilatory response to mild hypoxia, manifesting as hypoxic desensitization or a blunted response to new hypoxic stimuli in the *mdx* mice. Moreover, our HVR findings suggest, based on Dejours test and fast component of HCVR, that this blunted HVR is mediated by the CB (the major chemosensory organ for arterial oxygen, carbon dioxide and pH concentrations). These features affect the arterial blood gas concentration and pH as well as the ability to respond to hypoxic stresses *in vivo*. The absence of dystrophin in the CB, confirmed by immunoblotting and gene expression analyses, may provide a mechanistic basis for the impaired peripheral chemosensory drive and blunted ventilatory response in *mdx* mice.

Blunted HVR and impaired hypoxic stress test in *mdx* mice {#s4a}
----------------------------------------------------------

Using a custom built WBP chamber we recorded ventilatory values that are well within the range of previous reports studying ventilatory parameters in mice [@pone.0069567-Han1], [@pone.0069567-Han2], [@pone.0069567-Onodera1], [@pone.0069567-Soliz1], [@pone.0069567-Tankersley1], [@pone.0069567-Yamauchi1]. Consistent with most [@pone.0069567-DupontVersteegden1], [@pone.0069567-DupontVersteegden2], [@pone.0069567-Gayraud2], [@pone.0069567-Matecki1], [@pone.0069567-Han1], [@pone.0069567-Han2], [@pone.0069567-Onodera1], [@pone.0069567-Soliz1], [@pone.0069567-Tankersley1], [@pone.0069567-Yamauchi1] but not all reports [@pone.0069567-Huang1], [@pone.0069567-Ishizaki1], *mdx* mice showed a significantly lower *f* ~R~, reduced V~T~ and during normoxia compared to normal mice. ([Fig. 1](#pone-0069567-g001){ref-type="fig"} and [Table S1](#pone.0069567.s004){ref-type="supplementary-material"}). *Mdx* mice showed impairment of HVR when challenged with mild hypoxic challenges (FiO~2~ 18 and 15%), however, but not during moderate (FiO~2~ 10 and 12%) and severe hypoxic challenges (FiO~2~ 8%; [Figure 1B](#pone-0069567-g001){ref-type="fig"}). As expected for a small animal like the mouse, tachypnea rather than increasing V~T~ was the means utilized to achieve net changes in while responding to hypoxia.

The normoxic *f* ~R~ range reported in normal mice, independently of the strain, age and method of measurement (direct plethysmograph, pneumotachograph and WBP) varies between 2.8 and 5 Hz (167 and 300 breaths per minute) [@pone.0069567-Han1], [@pone.0069567-Han2], [@pone.0069567-Onodera1], [@pone.0069567-Tankersley1], [@pone.0069567-Adachi1], [@pone.0069567-Hickey1]. Our measurements were based on the guidelines for standard pre-clinical experiments in *mdx* mouse to minimize stress, behavioral and physical activity that might influence in the ventilatory measurements (see material & methods). The *f* ~R~ obtained in this study fit in this range for both normal and *mdx* mice (3.28±0.05 *vs.* 2.95±0.06 Hz, respectively). Age related changes in these parameters have shown by Dupont-Versteegden et al.; 3 month-old *mdx* mice have a higher *f* ~R~ compared to 1 year-old *mdx* mice and that 1 year-old *mdx* mice have lower *f* ~R~ than normal mice [@pone.0069567-DupontVersteegden1], [@pone.0069567-DupontVersteegden2]. In contrast, Ishizaki et al compared 2 and 4 months-old normal to age matched *mdx* mice and showed a significant decrease in *f* ~R~ and in 7 month-old *mdx* mice a significant increase in *f* ~R~ and a significant decrease in V~T~ [@pone.0069567-Ishizaki1]. Huang et al. showed a significant decrease in the *f* ~R~ and in V~T~ at 3 and 6 month-old *mdx* mice [@pone.0069567-Huang1]. However, the normoxic *f* ~R~ reported for normal and *mdx* mice by both Ishizaki et al (2008) and Huang et al (2011) studies are extremely elevated (c. 6 Hz or 400 breaths per minute) compared to previous reports from the most common inbred strains [@pone.0069567-Han1], [@pone.0069567-Han2], [@pone.0069567-Soliz1], [@pone.0069567-Tankersley1], [@pone.0069567-Yamauchi1], [@pone.0069567-Adachi1]. However, in agreement with our results and within the *f* ~R~ range reported for normal mice as discussed above [@pone.0069567-Han1], [@pone.0069567-Han2], [@pone.0069567-Onodera1], [@pone.0069567-Tankersley1], [@pone.0069567-Adachi1], [@pone.0069567-Hickey1], Dupont-Versteegden et al. have shown using a similar WBP chamber used by Ishizaki et al. and Huang et al. and with a similar procedure described on the published guidelines for standard pre-clinical experiments in *mdx* mouse [@pone.0069567-Willmann1] and used by us that 1 year-old *mdx* mice have lower *f* ~R~ than normal mice [@pone.0069567-DupontVersteegden1], [@pone.0069567-DupontVersteegden2].

To determine whether the blunted HVR was due to abnormal phrenic nerve discharge, we studied *in situ* phrenic nerve activity. The phrenic nerve discharge analysis demonstrated a significant reduction of *f* ~x~ in *mdx* mice during normoxia (FiO~2~ 21%) and at FiO~2~ 100% compared to normal mice, independently confirming the lower *f* ~R~ observed in the WBP experiments and suggesting abnormalities in the CB chemosensory response. However, our recordings were not designed to interrogate diaphragmatic function. The burst frequency analysis showed no difference between the genotypes indicating that the phrenic nerve\'s motor neurons activity is normal. Personius and co-workers previously showed that *in vitro* stimulation of the *mdx* mice phrenic nerve at 35 Hz (to simulate physiological firing frequency), showed an augmentation of neural transmission variability with reduced ability to precisely and consistently generate the same muscle force and a greater contractile fatigue in dystrophic diaphragm following both nerve and muscle stimulation [@pone.0069567-Personius1]. Although the cause of reduced performance of the phrenic nerve of *mdx* mice is unclear, the results along with diaphragmatic muscle damage [@pone.0069567-Stedman1] would explain, in part, the lower during normoxic conditions observed here.

We observed an impaired ability to respond abrupt change from normoxia to severe hypoxic challenges (PO~2~ 8%) in *mdx* mice compared to normal mice. Previously, it has been demonstrated that mice with different genetic backgrounds have different HVR patterns and resistance to hypoxia [@pone.0069567-Han1], [@pone.0069567-Tankersley1], [@pone.0069567-Adachi1], and those that display a blunted HVR response also have a weaker compensation in response to severe hypoxia [@pone.0069567-Adachi1]. Interestingly, we have previously reported that dystrophic *Drosophila* also has an impaired capacity to respond to hypoxic stress [@pone.0069567-Mosqueira2]. Our ventilatory data from *mdx* mice (bradypneic, blunted HVR during normoxia and lower resistance to severe hypoxia challenges) would also support previous data showing a severe functional deficit of the damaged diaphragm. This is of significance as the progression of the kyphosis would be predicted to further impair pulmonary function in *mdx* mice [@pone.0069567-Stedman1], [@pone.0069567-Laws1], as it does in DMD patients [@pone.0069567-Kennedy1], [@pone.0069567-Kinali1], [@pone.0069567-Kinali2].

Hypoxemia, hypercapnia and reduced CB chemosensory drive {#s4b}
--------------------------------------------------------

*Mdx* mice presented a blunted response to mild hypoxia and bradypenia during normoxic conditions compared to age-matched control mice. As expected, the major consequence of the chronic hypoventilation was altered blood gases, including hypoxemia, hypercapnia and acidosis. Our ventilatory and blood gas results are in line with previous data from *mdx* mice [@pone.0069567-DupontVersteegden1], [@pone.0069567-DupontVersteegden2] and resemble hypoventilated DMD patients with hypoxemia and hypercapnia [@pone.0069567-Baydur1], [@pone.0069567-Phillips1], [@pone.0069567-Melacini1], [@pone.0069567-Yotsukura1] and acidosis [@pone.0069567-Matsumura1], [@pone.0069567-Takasugi1]. As expected, we observed a significant increase in hematocrit in *mdx* mice, possibly due to hypoxic condition. Chronic hypoxia is known to induce erythropoiesis [@pone.0069567-Koistinen1], [@pone.0069567-Mosqueira3], [@pone.0069567-Ou1]. Our hematocrit values were in the range of values for hematocrit obtained from normal and *mdx* mice reported by others [@pone.0069567-DupontVersteegden1], [@pone.0069567-DupontVersteegden2], [@pone.0069567-Mosqueira3].

It is generally accepted that in mammals the CB play a central role in the regulation of ventilation and its activity is modulated by changes in the PaO~2~, PaCO~2~ and pH. The functional unit of chemoreception is called glomoid, composed by the chemoreceptors glomic cells (Type I cells), which is surrounded by sustentacular cells (Type II) cells and is innervated by sensory neurons of the carotid sinus nerve (CSN). The CSN, which somas are located in the petrosal ganglion, innervates the caudal area of the NTS, which then connects to the respiratory groups of the brain stem. Changes in these arterial parameters of PaO~2~, PaCO~2~ and pH depolarizes the membrane of glomic cells, increasing cytosolic \[Ca^2+^\], which results into release of excitatory neurotransmitters, increasing the activity of carotid sinus nerve. The increase of CB\'s activity and thus the firing activity of CSN results in an adaptive ventilatory response, such as HVR and HCVR [@pone.0069567-Eyzaguirre1], [@pone.0069567-Gonzalez1], [@pone.0069567-Teppema1]. Denervation or excision of CBs reduces or abolishes the HVR in rats, cats, dogs, goats and humans [@pone.0069567-Blain1], [@pone.0069567-Busch1], [@pone.0069567-Chiocchio1], [@pone.0069567-Curran1], [@pone.0069567-Hayashi1], [@pone.0069567-Long1], [@pone.0069567-Miller1], [@pone.0069567-Timmers1]. In mice, the HVR is abolished after CSN denervation, showing that hypoxia-induced increase (due to decrease of *f* ~R~ and no change in the V~T~) is mediated by CB [@pone.0069567-Izumizaki1]. CB denervation also causes attenuation of the HCVR; however, this attenuation is not observed in all species and it is chronically compensate by central chemoreceptors [@pone.0069567-Timmers1], [@pone.0069567-Blain2], [@pone.0069567-Mouradian1]. In this context, it has been shown that the CB is responsible for a greater-than-additive ventilatory response in awake and anesthetized animals when hypoxic and hypercapnic stimuli are given together, compared to only one stimulus separately [@pone.0069567-Daristotle1], [@pone.0069567-Lahiri1], [@pone.0069567-Lahiri2], [@pone.0069567-Lloyd1]. In mice, the CB can also drive phrenic nerve activity via the NTS and respiratory neurons [@pone.0069567-Eyzaguirre1], [@pone.0069567-Gonzalez1]. Chemo- or electrical stimulation of CSN increases phrenic nerve activity and thus ventilation [@pone.0069567-Dwinell1], [@pone.0069567-Ling1]. Bilateral denervation of the CB abolishes phrenic nerve activity induced by chemo- or electrical stimulation [@pone.0069567-Dwinell1], [@pone.0069567-Ling1]. One of the major consequences of the chronic hypoxemic condition is the desensitization response of the CB to hypoxic stimulus. This response is characterized by a blunted HVR to new hypoxic challenges and has been described in humans and animal models exposed to chronic hypoxia [@pone.0069567-Powell1], [@pone.0069567-Tatsumi1]. However, the role of dystrophin in the chemosensory response of the CB and the control of ventilation are unknown. Our ventilatory results together with the absence of gene and protein expression in *mdx* CB suggest that the absence of dystrophin in the CB may decrease the peripheral chemosensory sensitivity in *mdx* mice. Since the CB contains numerous cell types/structures including Type I and Type II cells, smooth muscle cells, ganglion cells and nerve endings that are all capable of expressing dystrophin it is currently unclear which cellular compartment(s) are responsible for the decreased chemosensory sensitivity we noted in *mdx* mice.

We performed the Dejours test to investigate the chemosensory drive of the CB chemoreceptors. Our results showed a significant difference in hyperoxia-induced attenuation of the *f* ~R~, suggesting an impairment of the chemosensory drive and thus an impairment of the CB response to different levels of oxygen ([Fig. 6](#pone-0069567-g006){ref-type="fig"}). This idea is also supported by our HVR experiment ([Figure 1](#pone-0069567-g001){ref-type="fig"}), in which *mdx* mice are unable to adapt their *f* ~R~ to a wide range of FiO~2~ (from 15 to 100%). We also showed in both awake and anesthetized animals that *mdx* mice presented similar responses as normal mice at mild and more severe hypoxic stimuli (from FiO~2~ 12 to 0%), suggesting that the HVR is affected only at physiological ranges of hypoxia.

HCVR and contribution of the CB to the fast component of HCVR {#s4c}
-------------------------------------------------------------

Consistent with previous studies, we found no impairment of overall (i.e. when considering both the fast and slow components) HCVR in 6--7 month old *mdx* mice compared to age-matched controls [@pone.0069567-Gayraud2], [@pone.0069567-Matecki1]. In general, both *mdx* and normal mice presented a steady and robust increase in *f* ~R~ and V~T~ after 60 seconds of exposure to all hypercapnic challenges. Only at 16 months-old *mdx* mice show a significant HCVR increase compared to normal mice [@pone.0069567-Gayraud2], [@pone.0069567-Matecki1]. Our results support the previously published HCVR results, where there is no difference between the two genotypes at 6--7 months-old. Studies show that, the HCVR occurs between 5--10 s after exposure to hypercapnia challenges and this response is delayed in CB chemodenervated dogs [@pone.0069567-Dejours1], [@pone.0069567-Green1], [@pone.0069567-Smith2]. Data from CB-denervated human [@pone.0069567-Dahan1], [@pone.0069567-StCroixCMC1] and animals [@pone.0069567-Rodman1], [@pone.0069567-Smith2], [@pone.0069567-Pan1] demonstrates that HCVR is mainly controlled by the central chemosensory neurons rather than CBs. However the CBs are responsible for 20--50% of the total HCVR [@pone.0069567-Pan1], [@pone.0069567-Bernards1], [@pone.0069567-Coles1], [@pone.0069567-Gautier1], [@pone.0069567-Dejours2], and are singularly responsible for the first seconds (fast component) of the HCVR [@pone.0069567-Dahan1], [@pone.0069567-Smith2], [@pone.0069567-Robbins1]. Consistent with this, we observed a significant attenuation of the *f* ~R~ in the HCVR of *mdx* mice compared to normal mice during the first 10 s of exposure to two protocols of hypercapnia (balanced in air or in oxygen), suggesting that CB chemosensitivity is attenuated due to dystrophin deficiency in mdx mice and the intact HCVR response after 60 s of hypercapnic stimulus suggests that the central chemoreceptor neurons are responsible for the late component of the HCVR observed in [Figure 2](#pone-0069567-g002){ref-type="fig"}.

Relevance to DMD and Conclusions {#s4d}
--------------------------------

Increasing our understanding of the mechanisms of respiratory failure is extremely important in the appropriate management and development of therapeutics for DMD. The lifespan of DMD patients is dramatically reduced once the VC falls below 1L [@pone.0069567-Phillips1]. The progressive decrease in VC is correlated with age and hypoxemia [@pone.0069567-Phillips1], [@pone.0069567-Melacini1], [@pone.0069567-Yotsukura1], [@pone.0069567-Phillips2]. Since hypoxia is known to cause impaired muscle function and muscle damage [@pone.0069567-Hoppeler1], [@pone.0069567-Koechlin1], [@pone.0069567-Man1], [@pone.0069567-Pistilli1], chronic hypoxia would be predicted to further aggravate the disease process. Indeed, 6 month-old *mdx* mice exposed to 8 h/day episodic hypoxia (PO~2~ 5%) for 12 weeks showed impaired diaphragmatic contraction relative to aged matched normoxic *mdx* mice [@pone.0069567-Farkas1]. While we are unaware of previous investigations of chemosensory respiratory drive integrity in DMD *per se*, DMD patients are known to suffer from hypoventilation and apneic episodes during sleep and decreased arterial oxygen saturation [@pone.0069567-Phillips2], [@pone.0069567-Barbe1] which may in part, be due to diminished CB-mediated drive mechanisms.

To facilitate our understanding of dystrophic patho-physiology as well as assist in therapeutic development, in this study we investigated respiratory control mechanisms in the *mdx* mouse model of DMD. *Mdx* mice had significant respiratory and systemic abnormalities as revealed by their respiratory parameters, HVR and blood gas analyses. The lack of dystrophin in *mdx* CB was functional, since *mdx* mice had a defective peripheral chemosensory drive that would be predicted to contribute, alongside the well documented diaphragmatic pathology, to the respiratory failure. Given the evolutionary conservation of the dystrophin gene as well as many components of the hypoxia sensing and respiratory functioning, we suggest that CB functioning and peripheral chemosensory drive mechanisms should be investigated in DMD patients as they may be compromised and indeed contribute to respiratory failure.
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**Photography of custom made WBP chamber and Nose Plethysmograph.** A. WBP with 150 ml volume. Inside the WBP chamber, a flat white surface to give stability to the mouse. B. The custom made Nose Plethysmograph from a 15 ml conical tube.
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Click here for additional data file.
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**Hypercapnic ventilatory response obtained from normal and** ***mdx*** **mice.** WBP from normal (empty bars) and *mdx* (filled bars) exposed to different levels of hypercapnia: FiCO~2~ 5 and 10% mixed with air or O~2~.A. Respiratory rate (*f* ~R~, Hz). B. Tidal volume normalized to body weight (V~T~, µL/g). C. Normalized minute ventilation (, µL/s/g). Mean ± SEM; \* p\<0.05; \*\* p\<0.01, n = 5.
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**Percentage of basal changed V~T~ during Dejour\'s Test.** Dejour\'s test V~T~ obtained from normal (empty bars) and *mdx* (filled bars) was normalized to the V~T~ obtained during normoxia. The difference did not reach statistical significance. Mean ± SEM; n = 5.
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**HVR for normal and** ***mdx*** **mice exposed to different FiO~2~.**
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**Phrenic nerve discharge from normal and** ***mdx*** **mice challenged to different FiO~2~ exposure.**
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**HCVR for normal and** ***mdx*** **mice challenged to different FiCO~2~ exposure.**
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**Chemosensory drive in** ***mdx*** **by Dejours maneuver.** Values were analyzed 10 s after being exposed to hyperoxia and normalized to normoxic baseline.
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**Early HCVR in** ***mdx*** **mice.** Values were analyzed 10 s after being exposed to hyperoxia and normalized to normoxic baseline.
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Click here for additional data file.
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